SPENCER LAULUSA: Open Payments
NPI 1447831961 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$163 in 9 payments from 7 companies in 2025. Trend: 2023 $114 · 2024 $128 · 2025 $163
Food & beverage: $163
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $38 |
| Novo Nordisk Inc | 2 | $29 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Verity Pharmaceuticals Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Boston Scientific Corporation | 1 | $14 |
Products named: Symbravo, CAPLYTA, VRAYLAR, Tlando, QULIPTA, AIRSUPRA, Ozempic, WaveWriter Alpha Prime 16.
Industry payments across UT — which companies pay providers there.
